Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Leena, Tuomivaara"'
Autor:
Heljä-Marja Surcel, Marjo Kuortti, Eero Pukkala, Tiina Petäjä, Kari Natunen, Katja Harjula, Tiina Eriksson, Mari Siitari-Mattila, Gary Dubin, Mari Hokkanen, Simopekka Vänskä, Pekka Nieminen, Jorma Paavonen, Leena Tuomivaara, Tapio Luostarinen, Anna Söderlund-Strand, Iacopo Baussano, Joakim Dillner, Matti Lehtinen, Sirpa Rekonen, Johanna Palmroth, Geoff P. Garnett, Dan Apter
Publikováno v:
International Journal of Cancer. 143:2299-2310
With optimal strategy, human papillomavirus (HPV) vaccines have the potential to control HPV. We have assessed vaccine efficacy (VE), herd effect (HE) of HPV vaccination and overall protective effectiveness (PE) against high-risk HPV infections by HP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd9599f4819ea83f6a4bc70c2364ce0d
https://doi.org/10.1002/ijc.31618
https://doi.org/10.1002/ijc.31618
Autor:
Sirpa Rekonen, Dan Apter, Iacopo Baussano, Kari Natunen, Marjo Kuortti, Leena Tuomivaara, Heljä-Marja Surcel, Matti Lehtinen, Eero Pukkala, Geoffrey Garnett, Anna Söderlund-Strand, Mari Hokkanen, Jorma Paavonen, Tiina Petäjä, Simopekka Vänskä, Tiina Eriksson, Johanna Palmroth, Joakim Dillner, Katja Harjula, Mari Siitari-Mattila, Gary Dubin, Tapio Luostarinen
Publikováno v:
International Journal of Cancer. 142:949-958
Human papillomavirus (HPV) vaccine is efficacious but the real-life effectiveness of gender-neutral and girls-only vaccination strategies is unknown. We report a community-randomized trial on the protective effectiveness [(PE) = vaccine efficacy (VE)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9afa7aeeadd287ed8570c1bf3e030097
https://doi.org/10.1002/ijc.31119
https://doi.org/10.1002/ijc.31119
Autor:
Matti, Lehtinen, Tapio, Luostarinen, Simopekka, Vänskä, Anna, Söderlund-Strand, Tiina, Eriksson, Kari, Natunen, Dan, Apter, Iacopo, Baussano, Katja, Harjula, Mari, Hokkanen, Marjo, Kuortti, Johanna, Palmroth, Tiina, Petäjä, Eero, Pukkala, Sirpa, Rekonen, Mari, Siitari-Mattila, Heljä-Marja, Surcel, Leena, Tuomivaara, Jorma, Paavonen, Pekka, Nieminen, Joakim, Dillner, Gary, Dubin, Geoff, Garnett
Publikováno v:
International journal of cancer. 143(9)
With optimal strategy, human papillomavirus (HPV) vaccines have the potential to control HPV. We have assessed vaccine efficacy (VE), herd effect (HE) of HPV vaccination and overall protective effectiveness (PE) against high-risk HPV infections by HP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b3da8027ba1bcbdefe9fe60d658f97d1
https://pubmed.ncbi.nlm.nih.gov/29845626
https://pubmed.ncbi.nlm.nih.gov/29845626
Autor:
Jorma Paavonen, Mari Siitari-Mattila, Eeva-Leena Korpivaara, Laura Kyhä-Österlund, Johanna Palmroth, Terhi Lunnas, Tapio Luostarinen, Sofia Svartsjö, Marjo Vilkki, Elise Kosunen, Matti Lehtinen, Susanna Salmivesi, Lubov Niemi, Gary Dubin, Rita Isaksson, Eero Pukkala, Dan Apter, Leena Tuomivaara, Tiina Petäjä, Sirpa Rekonen
Publikováno v:
University of Helsinki
Human papillomaviruses (HPVs, most notably types 16 and 18) cause cervical carcinoma, the second most common cancer among women. Vaccination of adolescents against HPV16/18 might prevent large proportion of cervical and other anogenital cancers. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2ef0b720b7b6aa642882bada83da4a
https://doi.org/10.1258/095646206778145550
https://doi.org/10.1258/095646206778145550
Autor:
K. Mäkikallio, Maritta Hippeläinen, Hannu Martikainen, Helena Tinkanen, M. Päkkilä, Seppo Heinonen, Juha Rasanen, Leena Tuomivaara, J.S. Tapanainen
Publikováno v:
Human Reproduction. 20:2211-2214
BACKGROUND: Poor ovarian and endometrial responses to gonadotrophin stimulation in assisted reproduction techniques lead to decreased pregnancy rates. The aim of the present study was to test the hypothesis that low-dose aspirin started prior to cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd807042263058548f02248bdfd0a263
https://doi.org/10.1093/humrep/dei020
https://doi.org/10.1093/humrep/dei020
Autor:
Kaisa Juntunen, Tuija Foudila, Outi Hovatta, Viveca Söderström-Anttila, Kristiina Aittomäki, Aila Tiitinen, Leena Tuomivaara
Publikováno v:
Human Reproduction. 17:124-127
BACKGROUND: An inactivating point mutation (Alal89Val) in the FSH receptor (FSHR) causes primary ovarian failure. It has not been known if FSH action is necessary during pregnancy and childbirth. METHODS: In 1991-2001, donated oocytes were used to tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce3119ddb16c8ec371e5299e71142e3
https://doi.org/10.1093/humrep/17.1.124
https://doi.org/10.1093/humrep/17.1.124
Autor:
Juha S. Tapanainen, Leena Tuomivaara, S. Vilska, Mauri Orava, Hannu Martikainen, Outi Hovatta, Aila Tiitinen, Candido Tomás, Christel Hydén-Granskog
Publikováno v:
Human Reproduction. 16:1900-1903
Background The main reason for adverse treatment outcome in assisted reproduction is the high rate of multiple pregnancies. The only strategy to avoid dizygotic twins is to transfer one embryo at a time. Methods A total of 144 women, who had had at l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c683103993edc27b42272467bac574a
https://doi.org/10.1093/humrep/16.9.1900
https://doi.org/10.1093/humrep/16.9.1900
Publikováno v:
Human Reproduction. 14:698-703
A total of 811 intrauterine insemination (IUI) cycles in which clomiphene citrate/human menopausal gonadotrophin (HMG) was used for ovarian stimulation were analysed retrospectively to identify prognostic factors regarding treatment outcome. The over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e53f3e952f33bfc9a8042ed2acc782c
https://doi.org/10.1093/humrep/14.3.698
https://doi.org/10.1093/humrep/14.3.698
Publikováno v:
Fertility and Sterility. 69:714-721
To study the mechanism of action of Implanon, a single-rod contraceptive implant containing etonogestrel, in healthy women during 3 years.Prospective, randomized comparison with Norplant. The study was conducted for 2 years in Sweden but was extended
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d685555f9035c37cadc0864079ae884
https://doi.org/10.1016/s0015-0282(98)00015-6
https://doi.org/10.1016/s0015-0282(98)00015-6
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 74:83-87
Objective: This prospective study was undertaken to examine the usefulness of a long gonadotrophin releasing hormone agonist (GnRH-a)/human menopausal gonadotrophin (hMG) protocol in intrauterine insemination (IUI) treatment. The results were compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe96d981771d8b66741c59fb9ef63b6a
https://doi.org/10.1016/s0301-2115(97)00086-9
https://doi.org/10.1016/s0301-2115(97)00086-9